Head-to-head · WeighScore
TrueMe vs Vita Bella
The verdict
TrueMe takes it — 67.6/100 to 64.9/100.
TrueMe grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. TrueMe is a cash-pay telehealth brand offering compounded semaglutide and tirzepatide with added B vitamins, alongside NAD+, sermorelin and glutathione.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | TrueMe | Vita Bella |
|---|---|---|
| WeighScore | 67.6/100 | 64.9/100 |
| Grade | C | C |
| Scorecard rank | #163 | #233 |
| Semaglutide | $159/mo (compounded) | Not disclosed |
| Tirzepatide | $189/mo (compounded) | $159/mo (2.5 mg dose, plus a separate fee, compounded) |
| Coverage | 6 states | 46 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #163 · C
Strengths
- One price covers consultation, medication, shipping, supplies and provider support, and the site states there are no separate membership fees
- Same price at every dose, so the cost does not climb as a provider titrates the dose upward
- Full pricing is published up front — no intake form is required before you can see what you will pay
- Carries a genuine LegitScript-issued seal (ID 50205625) that resolves on LegitScript's own asset host
- Names its telehealth platform (Telegra) and physician network (Strive), and the returns address names CarePoint Infusion Pharmacy in Stafford, Texas
Where it loses points
- Serves only six states (AZ, CO, MO, PA, TX, WI), far narrower coverage than most national GLP-1 telehealth
- Prices marketed per month are charged every 4 weeks at checkout — 13 charges a year, not 12
- You pay before completing the medical intake, and approval is not guaranteed at the moment you are charged
- The 3-month rates ($119 and $139/mo) are a single upfront charge of $357 or $417, not a lower monthly plan
- A Featured In strip shows CNN, Fox News, Forbes, New York Times and NPR logos with no linked coverage
Graded #233 · C
Strengths
- Offers both compounded semaglutide (from $109/mo) and tirzepatide (from $159/mo) at member pricing, with supplies and a B-6 add-in included
- Genuine LegitScript-certified website (seal #4395819) and a clearly disclosed legal entity, Vita Bella Health, LLC (Nevada)
- Broad access: care published for 46 states plus Washington, D.C., and HSA cards are accepted
- Fully remote telehealth with video provider consults and quarterly provider check-ins included in the membership
- Medications dispensed by US FDA-inspected compounding pharmacies; ondansetron for nausea provided at no extra charge
Where it loses points
- Advertised $109-$159 medication prices require a separate $129/mo membership plus a one-time $99 consult, pushing true cost to ~$238-288/mo
- Three-month minimum commitment before it renews month-to-month; no refunds on medications and all sales are final
- Compounding pharmacy partners are not named anywhere on the site — a transparency gap
- Compounded semaglutide and tirzepatide are not FDA-approved; only the dispensing pharmacies are described as FDA-inspected
- Disputes are subject to binding arbitration with a class-action waiver, governed by Nevada law (Las Vegas jurisdiction)
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.